For pharmaceutical manufacturers and formulators, securing a consistent supply of high-quality active pharmaceutical ingredients (APIs) is fundamental to product integrity and efficacy. Orlistat, identified by CAS number 96829-58-2, is a critical component in the development of anti-obesity medications. Its role as a lipase inhibitor makes it a sought-after pharmaceutical intermediate, but the sourcing process demands careful consideration of several factors, including purity, reliable suppliers, and precise product specifications.

Understanding the technical details of Orlistat is the first step. As a white crystalline powder, its purity levels are paramount. Pharmaceutical-grade Orlistat typically exceeds 99% purity, ensuring that the final drug product meets stringent regulatory standards. The molecular formula C29H53NO5 and molecular weight of 495.73 are key identifiers, alongside its EINECS number 639-755-1. When looking to buy Orlistat, manufacturers should pay close attention to the CAS number, as it is the universal identifier for this chemical compound. This meticulous approach to product identification and quality assurance is non-negotiable in the pharmaceutical industry.

The choice of supplier is equally critical. A reputable manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. not only provides the necessary documentation such as Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS) but also demonstrates a commitment to quality control throughout their production and supply chain. Factors like production capacity, adherence to GMP (Good Manufacturing Practice) standards, and the availability of logistical support, such as warehousing in key regions, contribute to a seamless procurement process. Exploring options for Orlistat purchase should involve evaluating potential suppliers based on their track record, transparency, and ability to meet specific order requirements, including packaging and delivery timelines.